Try the Demo today!
| SEC Filing | Insider | Company | Trade Date | Transaction | Shares | Avg. Price | Total | % Holdings | Return |
|---|---|---|---|---|---|---|---|---|---|
| 05-Oct-17 3:52 PM View:  | Orbimed Advisors LLC 10% Owner | Roka Bioscience, Inc. (ROKA) | 03-Oct-17 | Market Sale | 201,617 | $0.68 | $137,100.00 | (100%) 201.62K to 0 | 3% |
| 02-Oct-17 4:07 PM View: | Orbimed Advisors LLC 10% Owner | Roka Bioscience, Inc. (ROKA) | 29-Sep-17 | Market Sale | 94,134 | $0.74 | $69,659.20 | (32%) 295.75K to 201.62K | 10% |
| 02-Oct-17 4:07 PM View: | Orbimed Advisors LLC 10% Owner | Roka Bioscience, Inc. (ROKA) | 28-Sep-17 | Market Sale | 380,542 | $0.72 | $273,990.00 | (56%) 676.29K to 295.75K | 8% |
| 28-Sep-17 5:31 PM View: | Orbimed Advisors LLC 10% Owner | Roka Bioscience, Inc. (ROKA) | 27-Sep-17 | Market Sale | 52,799 | $0.92 | $48,575.10 | (7%) 729.09K to 676.29K | 28% |
| 28-Sep-17 5:31 PM View: | Orbimed Advisors LLC 10% Owner | Roka Bioscience, Inc. (ROKA) | 26-Sep-17 | Market Sale | 74,802 | $1.03 | $77,046.10 | (9%) 803.89K to 729.09K | 36% |
| 25-Aug-17 3:30 PM View: | Orbimed Advisors LLC 10% Owner | Roka Bioscience, Inc. (ROKA) | 24-Aug-17 | Market Sale | 13,200 | $1.50 | $19,800.00 | (2%) 817.09K to 803.89K | 56% |
| 25-Aug-17 3:30 PM View: | Orbimed Advisors LLC 10% Owner | Roka Bioscience, Inc. (ROKA) | 23-Aug-17 | Market Sale | 1,100 | $1.50 | $1,650.00 | (< 1%) 818.19K to 817.09K | 56% |
| 22-Aug-17 8:27 PM View: | Orbimed Advisors LLC 10% Owner | Roka Bioscience, Inc. (ROKA) | 22-Aug-17 | Market Sale | 5,500 | $1.52 | $8,360.00 | (< 1%) 823.69K to 818.19K | 56% |
| 22-Aug-17 8:27 PM View: | Orbimed Advisors LLC 10% Owner | Roka Bioscience, Inc. (ROKA) | 21-Aug-17 | Market Sale | 2,980 | $1.49 | $4,440.20 | (< 1%) 826.67K to 823.69K | 55% |
| 22-Aug-17 8:27 PM View: | Orbimed Advisors LLC 10% Owner | Roka Bioscience, Inc. (ROKA) | 18-Aug-17 | Market Sale | 66,796 | $1.52 | $101,530.00 | (7%) 893.47K to 826.67K | 56% |
| 10-Nov-16 4:15 PM View: | Mary Beth Duseau SVP, Chief Commercial Officer | Roka Bioscience, Inc. (ROKA) | 10-Nov-16 | Conversion | 1,429 | $7.00 | $10,003.00 | 100% 0 to 1.43K | |
| 10-Nov-16 4:16 PM View: | Valeriani Nicholas J Director | Roka Bioscience, Inc. (ROKA) | 10-Nov-16 | Conversion | 7,143 | $7.00 | $50,001.00 | 100% 0 to 7.14K | |
| 15-Feb-17 5:17 PM View: | Tpg Group Holdings (sbs) Ad... 10% Owner | Roka Bioscience, Inc. (ROKA) | 10-Nov-16 | Conversion | 571,429 | -- | -- | 191% 298.93K to 870.36K | |
| 10-Nov-16 4:16 PM View: | Boesgaard Lars Vice President, CFO | Roka Bioscience, Inc. (ROKA) | 10-Nov-16 | Conversion | 3,572 | $7.00 | $25,004.00 | 67% 5.37K to 8.94K | |
| 10-Nov-16 4:16 PM View: | Thomas Paul President and CEO Director | Roka Bioscience, Inc. (ROKA) | 10-Nov-16 | Conversion | 7,143 | $7.00 | $50,001.00 | 9% 78.35K to 85.49K | |
| 05-Jan-16 4:20 PM View: | Narajowski Walter M. Senior VP & General Manager | Roka Bioscience, Inc. (ROKA) | 31-Dec-15 | Payment of Exercise | 13,738 | $1.23 | $16,897.70 | (9%) 154.31K to 140.57K | 94% |
| 07-Dec-15 4:05 PM View: | Boesgaard Lars Vice President, CFO | Roka Bioscience, Inc. (ROKA) | 06-Dec-15 | Payment of Exercise | 128 | $1.43 | $183.04 | (< 1%) 53.79K to 53.66K | 95% |
| 09-Nov-15 4:15 PM View: | Sobieski Steven SVP & Chief Financial Officer | Roka Bioscience, Inc. (ROKA) | 06-Nov-15 | Payment of Exercise | 280 | $1.70 | $476.00 | (< 1%) 282.95K to 282.67K | 96% |
| 07-Oct-15 4:13 PM View: | Sobieski Steven SVP & Chief Financial Officer | Roka Bioscience, Inc. (ROKA) | 06-Oct-15 | Payment of Exercise | 280 | $1.94 | $543.20 | (< 1%) 283.23K to 282.95K | 96% |
| 08-Sep-15 4:06 PM View: | Sobieski Steven SVP & Chief Financial Officer | Roka Bioscience, Inc. (ROKA) | 06-Sep-15 | Payment of Exercise | 280 | $2.73 | $764.40 | (< 1%) 283.51K to 283.23K | 97% |
| 10-Aug-15 4:03 PM View: | Sobieski Steven SVP & Chief Financial Officer | Roka Bioscience, Inc. (ROKA) | 06-Aug-15 | Payment of Exercise | 280 | $2.89 | $809.20 | (< 1%) 283.79K to 283.51K | 98% |
| 08-Jul-15 4:08 PM View: | Sobieski Steven SVP & Chief Financial Officer | Roka Bioscience, Inc. (ROKA) | 06-Jul-15 | Payment of Exercise | 280 | $2.62 | $733.60 | (< 1%) 284.07K to 283.79K | 97% |
| 09-Jun-15 9:11 AM View: | Sobieski Steven SVP & Chief Financial Officer | Roka Bioscience, Inc. (ROKA) | 06-Jun-15 | Payment of Exercise | 280 | $2.52 | $705.60 | (< 1%) 284.35K to 284.07K | 97% |
| 08-May-15 4:02 PM View: | Sobieski Steven SVP & Chief Financial Officer | Roka Bioscience, Inc. (ROKA) | 06-May-15 | Payment of Exercise | 273 | $2.91 | $794.43 | (< 1%) 284.63K to 284.35K | 98% |
| 07-Apr-15 4:58 PM View: | McCardell Amyjo Senior Vice President | Roka Bioscience, Inc. (ROKA) | 06-Apr-15 | Payment of Exercise | 75 | $3.55 | $266.25 | (< 1%) 19.78K to 19.7K | 98% |
| 07-Apr-15 4:58 PM View: | Sobieski Steven SVP & Chief Financial Officer | Roka Bioscience, Inc. (ROKA) | 06-Apr-15 | Payment of Exercise | 273 | $3.55 | $969.15 | (< 1%) 284.9K to 284.63K | 98% |
| 10-Mar-15 4:05 PM View: | McCardell Amyjo Senior Vice President | Roka Bioscience, Inc. (ROKA) | 06-Mar-15 | Payment of Exercise | 74 | $4.47 | $330.78 | (< 1%) 19.85K to 19.78K | 98% |
| 10-Mar-15 4:05 PM View: | Sobieski Steven SVP & Chief Financial Officer | Roka Bioscience, Inc. (ROKA) | 06-Mar-15 | Payment of Exercise | 255 | $4.47 | $1,139.85 | (< 1%) 285.15K to 284.9K | 98% |
| 09-Feb-15 5:08 PM View: | Sobieski Steven SVP & Chief Financial Officer | Roka Bioscience, Inc. (ROKA) | 06-Feb-15 | Payment of Exercise | 344 | $4.50 | $1,548.00 | (< 1%) 285.5K to 285.15K | 98% |
| 09-Feb-15 5:07 PM View: | McCardell Amyjo Senior Vice President | Roka Bioscience, Inc. (ROKA) | 06-Feb-15 | Payment of Exercise | 75 | $4.50 | $337.50 | (< 1%) 19.93K to 19.85K | 98% |
| 06-Jan-15 4:02 PM View: | Narajowski Walter M. Senior VP & General Manager | Roka Bioscience, Inc. (ROKA) | 02-Jan-15 | Grant | 90,000 | -- | -- | 140% 64.31K to 154.31K | |
| 06-Jan-15 4:01 PM View: | Sobieski Steven SVP & Chief Financial Officer | Roka Bioscience, Inc. (ROKA) | 02-Jan-15 | Grant | 90,000 | -- | -- | 46% 195.5K to 285.5K | |
| 17-Nov-14 5:14 PM View: | McGirr David W J Director | Roka Bioscience, Inc. (ROKA) | 17-Nov-14 | Market Purchase | 20,994 | $3.65 | $76,697.40 | 72% 29.01K to 50.0K | (98%) |
| 17-Nov-14 5:14 PM View: | McGirr David W J Director | Roka Bioscience, Inc. (ROKA) | 14-Nov-14 | Market Purchase | 29,006 | $3.57 | $103,424.00 | 100% 0 to 29.01K | (98%) |
| 24-Jul-14 5:07 PM View: | Orbimed Advisors LLC 10% Owner | Roka Bioscience, Inc. (ROKA) | 22-Jul-14 | Conversion | 2,832,360 | -- | -- | 59855% 4.74K to 2.84M | |
| 22-Jul-14 5:07 PM View: | New Enterprise Associates 1... 10% Owner | Roka Bioscience, Inc. (ROKA) | 22-Jul-14 | Purchase | 383,333 | $12.00 | $4,600,000.00 | 14% 2.83M to 3.22M | |
| 22-Jul-14 5:11 PM View: | Barris Peter J 10% Owner | Roka Bioscience, Inc. (ROKA) | 22-Jul-14 | Conversion Duplicate | 2,828,740 | -- | -- | 59754% 4.74K to 2.83M | |
| 22-Jul-14 5:10 PM View: | Baskett Forest 10% Owner | Roka Bioscience, Inc. (ROKA) | 22-Jul-14 | Purchase Duplicate | 383,333 | $12.00 | $4,600,000.00 | 14% 2.83M to 3.22M | |
| 22-Jul-14 5:09 PM View: | Kerins Patrick J 10% Owner | Roka Bioscience, Inc. (ROKA) | 22-Jul-14 | Conversion Duplicate | 2,828,740 | -- | -- | 59754% 4.74K to 2.83M | |
| 22-Jul-14 5:09 PM View: | Kolluri Krishna Kittu 10% Owner | Roka Bioscience, Inc. (ROKA) | 22-Jul-14 | Purchase Duplicate | 383,333 | $12.00 | $4,600,000.00 | 14% 2.83M to 3.22M | |
| 22-Jul-14 5:09 PM View: | Sandell Scott D 10% Owner | Roka Bioscience, Inc. (ROKA) | 22-Jul-14 | Conversion Duplicate | 2,828,740 | -- | -- | 59754% 4.74K to 2.83M | |
| 22-Jul-14 5:08 PM View: | Viswanathan Ravi 10% Owner | Roka Bioscience, Inc. (ROKA) | 22-Jul-14 | Purchase Duplicate | 383,333 | $12.00 | $4,600,000.00 | 14% 2.83M to 3.22M | |
| 24-Jul-14 4:45 PM View: | Tpg Group Holdings (sbs) Ad... 10% Owner | Roka Bioscience, Inc. (ROKA) | 22-Jul-14 | Purchase | 350,000 | -- | -- | 13% 2.64M to 2.99M | |
| 24-Jul-14 5:09 PM View: | Silverstein Jonathan Director 10% Owner | Roka Bioscience, Inc. (ROKA) | 22-Jul-14 | Conversion Duplicate | 2,832,360 | -- | -- | 59855% 4.74K to 2.84M | |
| 24-Jul-14 5:07 PM View: | Orbimed Advisors LLC 10% Owner | Roka Bioscience, Inc. (ROKA) | 22-Jul-14 | Purchase Duplicate | 383,333 | $12.00 | $4,600,000.00 | 14% 2.84M to 3.22M | |
| 22-Jul-14 5:10 PM View: | Barrett M James Director 10% Owner | Roka Bioscience, Inc. (ROKA) | 22-Jul-14 | Conversion Duplicate | 2,828,740 | -- | -- | 59754% 4.74K to 2.83M | |
| 22-Jul-14 5:11 PM View: | Barris Peter J 10% Owner | Roka Bioscience, Inc. (ROKA) | 22-Jul-14 | Purchase Duplicate | 383,333 | $12.00 | $4,600,000.00 | 14% 2.83M to 3.22M | |
| 22-Jul-14 5:10 PM View: | Drant Ryan D 10% Owner | Roka Bioscience, Inc. (ROKA) | 22-Jul-14 | Conversion Duplicate | 2,828,740 | -- | -- | 59754% 4.74K to 2.83M | |
| 22-Jul-14 5:09 PM View: | Kerins Patrick J 10% Owner | Roka Bioscience, Inc. (ROKA) | 22-Jul-14 | Purchase Duplicate | 383,333 | $12.00 | $4,600,000.00 | 14% 2.83M to 3.22M | |
| 22-Jul-14 5:08 PM View: | Mott David M 10% Owner | Roka Bioscience, Inc. (ROKA) | 22-Jul-14 | Conversion Duplicate | 2,828,740 | -- | -- | 59754% 4.74K to 2.83M |
